Skip to main content

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Investor Investigation Over Possible Wrongdoing Announced

  • If you purchased shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

December 5, 2016 (Shareholders Foundation) - An investigation on behalf of investors in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) was announced over potential breaches of fiduciary duties by certain directors at Amicus Therapeutics. The investigation by a law firm concerns whether certain Amicus Therapeutics directors breached their fiduciary duties and caused damage to the co...

You must register (for free) or login to view the entire investigation.